More recently, protein D-containing pneumococcal conjugate formulations (PHiD-CV) have been shown to induce anti-protein D responses and to reduce NTHi carriage and NTHi-positive middle ear infections [77]. This evidence concerns the gene DHRS2 and infectious otitis media.